Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Index by author

March-April 2006; Volume 26,Issue 2B
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Accardi, L.

    1. You have access
      Matrix Metalloproteinase-2 (MMP-2) and its Tissue Inhibitor (TIMP-2) are Prognostic Factors in Cervical Cancer, Related to Invasive Disease but not to High-risk Human Papillomavirus (HPV) or Virus Persistence after Treatment of CIN
      M. BRANCA, M. CIOTTI, C. GIORGI, D. SANTINI, L. DI BONITO, S. COSTA, A. BENEDETTO, D. BONIFACIO, P. DI BONITO, P. PABA, L. ACCARDI, S. SYRJÄNEN, C. FAVALLI, K. SYRJÄNEN and HPV-PathogenISS Study Group
      Anticancer Research March 2006, 26 (2B) 1543-1556;
  2. Adamou, ADAMOS

    1. You have access
      Expression of p27KIP1, p21WAF1 and p53 does Not Correlate with Prognosis in Node-negative Invasive Ductal Carcinoma of the Breast
      HELEN P. KOUREA, ANGELOS K. KOUTRAS, VASSILIKI ZOLOTA, IRENE GRIMANI, EVANGELOS TZORACOELEFTHERAKIS, DIMITRIOS KOUKOURAS, GEORGE FOUNTZILAS, HELEN GOGAS, KYRIAKOS KYRIAKOU, ADAMOS ADAMOU and HARALAMBOS P. KALOFONOS
      Anticancer Research March 2006, 26 (2B) 1657-1668;
  3. Ajiki, TETSUO

    1. You have access
      Thymidylate Synthase and Dihydropyrimidine Dehydrogenase Expressions in Gallbladder Cancer
      TETSUO AJIKI, KENRO HIRATA, TARO OKAZAKI, HIDEKI HORIUCHI, TSUNENORI FUJITA, KAZUTO HABARA, TAKASHI KAMIGAKI, YASUYUKI SUZUKI and YOSHIKAZU KURODA
      Anticancer Research March 2006, 26 (2B) 1391-1396;
  4. Alldinger, INGO

    1. You have access
      Retroperitoneal Soft Tissue Sarcomas: Prognosis and Treatment of Primary and Recurrent Disease in 117 Patients
      INGO ALLDINGER, QIN YANG, CHRISTIAN PILARSKY, HANS-DETLEV SAEGER, WOLFRAM T. KNOEFEL and MATTHIAS PEIPER
      Anticancer Research March 2006, 26 (2B) 1577-1581;
  5. Antoniou, D.

    1. You have access
      Alternate Paclitaxel-Gemcitabine and Paclitaxel-Vinorelbine Biweekly Administration in Non-small Cell Lung Cancer Patients: a Phase II Study
      J. DIMITROULIS, M. TOUBIS, D. ANTONIOU, C. MAROSIS, U. ARMENAKI, G.P. STATHOPOULOS, P. GIAMBOUDAKIS, M. VESLEMES, P. MICHALOPOULOU, F. CHRISTOU, N. GEORGATOU, T. GRIGORATOU, D. KARAINDROS, K. KATIS and SOLCA Study Group
      Anticancer Research March 2006, 26 (2B) 1397-1402;
  6. Aoki, MASAHIKO

    1. You have access
      Results of Radiation Therapy for Superficial Esophageal Cancer using the Standard Radiotherapy Method Recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group
      KENJI NEMOTO, SHOGO YAMADA, MASAMICHI NISHIO, MASAHIKO AOKI, RYUJI NAKAMURA, YASUO MATSUMOTO, RYUTA SASAMOTO, YOSHIHIRO SAITOH, MAKOTO TAKAYAMA, NORIO MITSUHASHI, KOHTARO GOMI, NAOTO KANESAKA, MASAO KOBAYASHI, HIROSHI OHNISHI, SHIGERU SASAKI, HIROYASU TAMAMURA, MICHIHIDE MITSUMORI, YASUMASA NISHIMURA, KAYOKO TSUJINO, MITSUHIRO TAKEMOTO, NOBUE UCHIDA, MICHINORI YAMAMOTO, YOSHIYUKI SHIOYAMA, KOHICHI HIRAKAWA and SEIJI ONO
      Anticancer Research March 2006, 26 (2B) 1507-1512;
  7. Araki, KEN-ICHIRO

    1. You have access
      Clinicopathological Characteristics and Outcome Indicators of Stage II Gastric Cancer According to the Japanese Classification of Gastric Cancer
      HITOSHI OJIMA, KEN-ICHIRO ARAKI, TOSHIHIDE KATO, KAORI OKAMURA, RYOKUHEI MANDA, ISAO HIRAYAMA, YASUO HOSOUCHI, YASUJI NISHIDA and HIROYUKI KUWANO
      Anticancer Research March 2006, 26 (2B) 1385-1390;
  8. Araya, MASAYUKI

    1. You have access
      Influence of Age on the Pattern and Outcome of External Beam Radiotherapy for Clinically Localized Prostate Cancer
      KAZUHIKO OGAWA, KATSUMASA NAKAMURA, HIROSHI ONISHI, MASAHIKO KOIZUMI, TOMONARI SASAKI, MASAYUKI ARAYA, YUUKI MIYABE, YUUKI OTANI, TERUKI TESHIMA and JAPANESE PATTERNS of CARE STUDY WORKING SUBGROUP of PROSTATE CANCER
      Anticancer Research March 2006, 26 (2B) 1319-1325;
  9. Ardavanis, ALEXANDROS S.

    1. You have access
      Salvage Treatment with Single-agent Capecitabine in Patients with Heavily Pretreated Advanced Colorectal Cancer
      ALEXANDROS S. ARDAVANIS, GEORGIOS N. IOANNIDIS, GEORGE S. ORPHANOS and GERASSIMOS A. RIGATOS
      Anticancer Research March 2006, 26 (2B) 1669-1672;
  10. Arifin, MUHAMAD-THOHAR

    1. You have access
      Prognosis of Cerebellar Glioblastomas: Correlation Between Prognosis and Immunoreactivity for Epidermal Growth Factor Receptor Compared with Supratentorial Glioblastomas
      TAIICHI SAITO, SEIJI HAMA, YOSHINORI KAJIWARA, KAZUHIKO SUGIYAMA, FUMIYUKI YAMASAKI, MUHAMAD-THOHAR ARIFIN, KAZUNORI ARITA and KAORU KURISU
      Anticancer Research March 2006, 26 (2B) 1351-1357;
« Previous (Pages : 1 2 3 4 5 6 ... 39) Next »
Back to top
PreviousNext

In this issue

Anticancer Research: 26 (2B)
Anticancer Research
Vol. 26, Issue 2B
March-April 2006
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire